FDA Approved: LUZU — Supplemental Application (Bausch Health US, LLC)

View source ↗

Summary

The FDA has approved a supplemental application for LUZU (luliconazole) submitted by Bausch Health US, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinea Corporis
• Tinea Cruris
• Tinea Pedis

Drugs mentioned

• LUZU (luliconazole)

Snippet

SUPPL AP for LUZU (LULICONAZOLE)